Revolution Medicines Inc
F:42Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revolution Medicines Inc
F:42Z
|
US |
|
Eagle Materials Inc
F:E5M
|
US |
|
S
|
Summit Materials Inc
LSE:0LAI
|
US |
|
S
|
Silvercorp Metals Inc
XMUN:S9Y
|
CA |
|
Arko Corp.
NASDAQ:ARKO
|
US |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
V
|
Vector Group Ltd
F:VGR
|
US |
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
Promotica SpA
MIL:PMT
|
IT |
|
S
|
Saul Centers Inc
F:SA4
|
US |
|
P
|
Public Storage
SWB:PUP
|
US |
|
C
|
Chorus Ltd
SWB:7CH
|
NZ |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
D
|
Deutsche Bank AG
XMUN:DBK
|
DE |
|
V
|
ViacomCBS Inc
F:0VV
|
US |
Wall St Price Targets
42Z Price Targets Summary
Revolution Medicines Inc
According to Wall Street analysts, the average 1-year price target for
42Z is 58.43 EUR with a low forecast of 50.92 EUR and a high forecast of 84.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 42Z's stock price target?
Price Target
58.43
EUR
According to Wall Street analysts, the average 1-year price target for
42Z is 58.43 EUR with a low forecast of 50.92 EUR and a high forecast of 84.38 EUR.